
Uppsala Reports editor
@UMCGlobalSafety
Prof. Hervé Le Louët has resigned from his position as CEO of UMC due to family reasons. The recruitment process for next CEO starts immediately. During this interim period, Deputy CEO and former CFO, Birgitta Lindner, will serve as acting CEO, with full support from the Board.
During Le Louët’s tenure as CEO, UMC delivered impressive results. He helped drive forward necessary structural and strategic changes that will continue to be implemented. The Board thanks him for his work and wishes him all the best in the next phase of his career.
UMC’s dedicated and skilled staff will continue business as usual, pursuing their duties in line with the strategy and assignments set by the Board.
UMC today announced the forthcoming retirement of its longstanding director, Marie Lindquist, and the appointment of Hervé Le Louët as the organisation’s new CEO.
WHO programme / 21 August 2020
Luxembourg joined the WHO Programme for International Drug Monitoring in 2020, and being part of the network has already supported the growth of the pharmacovigilance department.
WHO programme / 04 May 2022
Recent additions mean the WHO Programme for International Drug Monitoring now stands at 143 full members and 28 associate members.
WHO programme / 30 March 2021